KAYA — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Upheal is an AI-native electronic health record (EHR) platform for therapists that generates clinical progress notes from sessions and includes scheduling, billing, telehealth, and compliance tools.
AI & Machine LearningDigital HealthMental HealthNew York, US
Juraj Chrappa(Executive Officer, Director)Karolina Mrozkova(Director)Martin Horvath(Executive Officer, Director)
Board seatTomas Pacinda· per SEC Form D
Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development.
AI & Machine LearningBiotechDeep TechHealthtechOxford, GB
Miroslav Gasparek(Founder)inMarian Kupculak(Founder)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.